Danny Muehlschlegel was awarded a grant from the NIH National Heart, Lung and Blood Institute for my project entitled “Rheumatic heart disease genetics (RECHARGE)” to perform whole exome sequencing on 250 patients with severe rheumatic heart disease.
Jochen “Danny” Muehlschlegel, MD, MMSc, director of Cardiovascular Anesthesia Research at BWH, was awarded a R01 grant from The National Heart, Lung, and Blood Institute (NHLBI) for his research on genetics of gene expression. This $1.25 million grant will span a five-year period.
Muehlschlegel's project will look at the genetic factors of ischemic heart disease, a highly heritable disorder, and the leading cause of mortality worldwide. The goal is to develop insights that may facilitate the development of new therapeutic strategies to alleviate the burden of myocardial injury in humans.
The NHLBI provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.